Evaluation of a Simple-Prep Controlled Embolic
NCT: NCT06453642 · ACTIVE_NOT_RECRUITING
NCT IDNCT06453642
StatusACTIVE_NOT_RECRUITING
Start Date2024-11-18
Completion2026-09
Brief Summary
The objective of this study is to evaluate the safety and effectiveness of the GPX® Embolic Device when used as indicated for embolization requiring distal vessel penetration in 114 subjects in up to 25 investigational sites in the USA, New Zealand, and Canada.
Frequently Asked Questions
What is Evaluation of a Simple-Prep Controlled Embolic?
Evaluation of a Simple-Prep Controlled Embolic is a clinical trial registered under NCT06453642. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT06453642?
The current status of NCT06453642 (Evaluation of a Simple-Prep Controlled Embolic) is: ACTIVE_NOT_RECRUITING.
When did Evaluation of a Simple-Prep Controlled Embolic start?
Evaluation of a Simple-Prep Controlled Embolic started on 2024-11-18.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.